Cofco Historical Cash Flow
| 000930 Stock | 5.78 0.04 0.69% |
Analysis of Cofco Biochemical cash flow over time is an excellent tool to project Cofco Biochemical Anhui future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 547.3 M or Total Cash From Operating Activities of 2.1 B as it is a great indicator of Cofco Biochemical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Cofco Biochemical Anhui latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cofco Biochemical Anhui is a good buy for the upcoming year.
Cofco |
About Cofco Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cofco balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cofco's non-liquid assets can be easily converted into cash.
Cofco Biochemical Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Cofco Biochemical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cofco Biochemical Anhui current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cofco Biochemical Anhui. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Cofco Biochemical's Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 2.1 B, whereas Capital Expenditures is forecasted to decline to about 547.3 M.
Cofco Biochemical cash flow statement Correlations
Click cells to compare fundamentals
Cofco Biochemical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cofco Biochemical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 196.0M | 164.4M | 277.3M | 554.7M | 1.2B | 1.2B | |
| Capital Expenditures | 900.8M | 987.5M | 1.1B | 565.8M | 634.5M | 547.3M | |
| Total Cash From Operating Activities | 3.6B | (2.9B) | 4.8B | 708.4M | 2.0B | 2.1B | |
| Net Income | 592.8M | 593.1M | 1.1B | 1.1B | (601.6M) | (571.5M) | |
| Other Cashflows From Financing Activities | (169.4M) | (43.6M) | (50.0M) | 45.0M | 40.5M | 38.5M | |
| Total Cash From Financing Activities | 1.3B | (3.1B) | 3.8B | (3.7B) | (3.3B) | (3.2B) | |
| Other Cashflows From Investing Activities | (32.1M) | 32.3M | (13.6M) | 11.0M | 9.9M | 9.4M | |
| Change To Account Receivables | (629.1M) | 960.8M | (2.3B) | 2.4B | 2.8B | 2.9B | |
| Change To Inventory | 983.4M | (2.5B) | 760.3M | 83.1M | 679.8M | 713.8M | |
| Change In Cash | (69.2M) | (55.8M) | 467.7M | (146.1M) | 516.0M | 541.8M | |
| Net Borrowings | (2.7B) | 3.9B | (3.4B) | (84.6M) | (76.1M) | (79.9M) | |
| Total Cashflows From Investing Activities | (854.7M) | (630.4M) | (899.0M) | (667.9M) | (601.1M) | (631.2M) | |
| Depreciation | 425.3M | 436.4M | 449.8M | 453.4M | 491.8M | 479.5M | |
| Change To Netincome | 941.0M | 481.4M | 530.9M | 441.6M | 397.4M | 451.0M | |
| Change To Liabilities | (196.9M) | (515.9M) | (273.5M) | 267.4M | (476.7M) | 0.0 | |
| End Period Cash Flow | 697.2M | 641.4M | 1.1B | 963.0M | 1.5B | 933.6M | |
| Free Cash Flow | 2.7B | (3.9B) | 3.7B | 142.7M | 1.3B | 1.4B | |
| Change In Working Capital | 1.7B | (4.5B) | 2.7B | (1.3B) | 1.4B | 1.4B | |
| Begin Period Cash Flow | 766.4M | 697.2M | 641.4M | 1.1B | 963.0M | 940.8M | |
| Other Non Cash Items | 198.6M | 138.5M | 196.3M | 120.7M | 130.4M | 125.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cofco Stock
The Cash Flow Statement is a financial statement that shows how changes in Cofco balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cofco's non-liquid assets can be easily converted into cash.